N-myc Gene Expression in Medulloblastoma
Author Information
Author(s): J.A. Garson, L.F. Pemberton, P.W. Sheppard, I.M. Varndell, H.B. Coakham, J.T. Kemshead
Primary Institution: Imperial Cancer Research Fund Oncology Laboratory
Hypothesis
Does N-myc gene expression correlate with prognosis in medulloblastoma?
Conclusion
The study found that N-myc gene was not amplified in medulloblastoma samples, but its overexpression was noted in some cases, suggesting a potential link to patient outcomes.
Supporting Evidence
- None of the nine medulloblastoma samples analyzed showed N-myc amplification.
- Over-expression of the N-myc gene was found in six of the eleven samples analyzed.
- A trend towards longer disease-free survival was noted in patients with low levels of N-myc protein.
Takeaway
This study looked at a type of brain tumor called medulloblastoma and found that while a specific gene (N-myc) wasn't amplified, it was overexpressed in some tumors, which might affect how well patients do.
Methodology
The study used Southern blot analysis, immunocytochemistry, and Western blot analysis to examine N-myc gene expression in medulloblastoma samples.
Limitations
The small sample size and the inability to perform all investigations on each case due to limited fresh tissue.
Want to read the original?
Access the complete publication on the publisher's website